NASDAQ: UG
United Guardian Inc Stock

$8.54+0.30 (+3.64%)
Updated Apr 21, 2025
UG Price
$8.54
Fair Value Price
$12.49
Market Cap
$39.21M
52 Week Low
$7.73
52 Week High
$16.25
P/E
12.02x
P/B
3.3x
P/S
3.61x
PEG
N/A
Dividend Yield
4.1%
Revenue
$12.18M
Earnings
$3.25M
Gross Margin
53%
Operating Margin
33.73%
Profit Margin
26.7%
Debt to Equity
0.16
Operating Cash Flow
$3M
Beta
0.23
Next Earnings
May 8, 2025
Ex-Dividend
N/A
Next Dividend
N/A

UG Overview

United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; LUBRAJEL NATURAL consisting of natural ingredients for cosmetic use; LUBRAJEL MARINE; LUBRASIL II SB, a special formulation of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base; LUBRAJEL II XD; B-122, a powdered lubricant that is used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; KLENSOFT, a surfactant, which is used in shampoos, shower gels, makeup removers, and other cosmetic formulations; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, cleansers, and other cosmetics. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL LC and LUBRAJEL FA that are LUBRAJEL formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial product to treat infections in the urinary bladder, and localized infections in the peritoneum, as well as eye, ear, nose and throat, and sinuses. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and development primarily related to the development of cosmetic ingredients. It markets its products through marketing partners, distributors, and wholesalers. The company was founded in 1942 and is based in Hauppauge, New York.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine UG's potential to beat the market

Zen Rating Component Grades

N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Household & Personal Product

Industry Rating
C
UG
Ranked
Unranked of 25

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$25.84B
$63.67C
$3.81C
View Top Household & Personal Product Stocks

Be the first to know about important UG news, forecast changes, insider trades & much more!

Overview

Due Diligence Score

Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how UG scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

UG ($8.54) is undervalued by 31.67% relative to our estimate of its Fair Value price of $12.49 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
UG ($8.54) is significantly undervalued by 31.67% relative to our estimate of its Fair Value price of $12.49 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
UG was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more UG due diligence checks available for Premium users.

Valuation

UG fair value

Fair Value of UG stock based on Discounted Cash Flow (DCF)

Price
$8.54
Fair Value
$12.49
Undervalued by
31.63%
UG ($8.54) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
UG ($8.54) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
UG was unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

UG price to earnings (PE)

For valuing profitable companies with steady earnings

Company
12.02x
Industry
25.75x
Market
27.14x
UG is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
UG is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

UG price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
3.3x
Industry
7.46x
UG is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

UG's financial health

Profit margin

Revenue
$2.5M
Net Income
$503.7k
Profit Margin
20.3%
UG's Earnings (EBIT) of $4.11M... subscribe to Premium to read more.
Interest Coverage Financials
UG's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$13.8M
Liabilities
$1.9M
Debt to equity
0.16
UG's short-term assets ($12.67M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
UG's short-term assets ($12.67M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
UG's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
UG's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$269.3k
Investing
-$835.6k
Financing
$0.0
UG's operating cash flow ($3.47M)... subscribe to Premium to read more.
Debt Coverage Financials

UG vs Household & Personal Product Stocks

TickerZen RatingMarket Cap1d %P/EP/B
UG$39.21M+3.53%12.02x3.30x
GROVC$42.16M-5.41%-1.38x-4.93x
RAY$48.26M+7.45%43.49x5.13x
MTEX$18.01M-0.27%7.18x2.09x
BSLK$8.73M-0.39%-0.06x-1.01x

United Guardian Stock FAQ

What is United Guardian's quote symbol?

(NASDAQ: UG) United Guardian trades on the NASDAQ under the ticker symbol UG. United Guardian stock quotes can also be displayed as NASDAQ: UG.

If you're new to stock investing, here's how to buy United Guardian stock.

What is the 52 week high and low for United Guardian (NASDAQ: UG)?

(NASDAQ: UG) United Guardian's 52-week high was $16.25, and its 52-week low was $7.73. It is currently -47.48% from its 52-week high and 10.41% from its 52-week low.

How much is United Guardian stock worth today?

(NASDAQ: UG) United Guardian currently has 4,594,319 outstanding shares. With United Guardian stock trading at $8.54 per share, the total value of United Guardian stock (market capitalization) is $39.21M.

United Guardian stock was originally listed at a price of $4.25 in Dec 31, 1997. If you had invested in United Guardian stock at $4.25, your return over the last 27 years would have been 100.82%, for an annualized return of 2.62% (not including any dividends or dividend reinvestments).

How much is United Guardian's stock price per share?

(NASDAQ: UG) United Guardian stock price per share is $8.54 today (as of Apr 21, 2025).

What is United Guardian's Market Cap?

(NASDAQ: UG) United Guardian's market cap is $39.21M, as of Apr 22, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

United Guardian's market cap is calculated by multiplying UG's current stock price of $8.54 by UG's total outstanding shares of 4,594,319.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.